Famotidine/Naproxen
法莫替丁/萘普生
Report date: 2022/01/14 13:23:58
Base Information
Drug NameFamotidine/Naproxen
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes NaproxenFamotidine
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHorizon Therapeutics PLC
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHorizon Therapeutics PLC
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A